Latest Breaking News On - நிறைவு மணி - Page 22 : comparemela.com

Annovis Bio, Inc.: Annovis Bio to Ring Closing Bell at the New York Stock Exchange Berwyn, Pennsylvania (Newsfile Corp. - May 10, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, is pleased to announce that its CEO Maria Maccecchini, Ph.D. will ring The Closing Bell at the New York Stock Exchange (NYSE) today, May 10, to celebrate the recent reporting of positive interim data from its ongoing Phase 2a trial in AD and PD. We are honored to ring the Closing Bell, and we want to thank our investors for their continued support, said Dr. Maccecchini. Considering the positive initial interim data we reported in March, we believe Annovis is entering a very exciting period of corporate development. Our two ongoing Phase 2a trials are nearing completion, and we look forward to sharing additional data in the coming months that should set the stage for

United statesMaria maccecchiniAnnovis bioExchange commissionYork stock exchangePennsylvania newsfile corpAnnovis bio incNew york stock exchangeRedchip companies incClosing bellDown syndromeAnnual reportஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகுயார்க் ஸ்டாக் பரிமாற்றம்புதியது யார்க் ஸ்டாக் பரிமாற்றம்